Amgen Inc. (AMGN) Q3 2022 Earnings Call Transcript

Amgen Inc. (NASDAQ:NASDAQ:AMGN) Q3 2022 Earnings Conference Call November 03, 2022, 04:30 PM ET Company Participants Arvind Sood - VP, IR Bob Bradway - Chairman and CEO Peter Griffith - CFO...

Related Keywords

Germany ,Puerto Rico ,Japan ,United States ,North Carolina ,China ,Ohio ,Turkey ,America ,American ,Robyn Karnauskas ,David Risinger ,Tim Anderson ,Dave Reese ,Evan Seigerman ,Carter Gould ,Michael Yee ,Salveen Richter ,Murdo Gordon ,Peter Griffith ,Jay Olson ,Geoffrey Meacham ,Bob Bradway ,Yaron Werber ,David Reese ,Matthew Harrison ,Colin Bristow ,Michael Schmidt ,Mohit Bansal ,Morgan Stanley ,Company Participants ,Amgen ,American Heart Association ,Goldman Sachs ,Nasdaq ,European Union ,Wolfe Research ,World Congress On Insulin Resistance ,China National Reimbursement Drug List ,China National Drug Reimbursement List ,Barclays ,Wells Fargo ,Kyowa Kirin Corporation ,Amgen Inc ,Conference Call November ,Global Commercial ,Third Quarter ,Results Conference ,Arvind Sood ,Vice President ,Inflation Reduction ,National Reimbursement Drug List ,World Congress ,Insulin Resistance ,Cardiovascular Disease Hybrid Conference ,Otezla Phase ,Umer Raffat ,National Drug Reimbursement ,